Search





Search





Markets
/
Stocks
/
abvc
/

ABVC Biopharma Inc

ABVC

Add to Watchlist

1.010USD

-0.070-6.48%

Close 07-31 16:00（ET）Quotes delayed by 15 min

26.26MMarket Cap

LossP/E TTM

ABVC Biopharma Inc

1.010

-0.070-6.48%

Financial Summary Income Statement Balance Sheet Cash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial Summary Income Statement Balance Sheet Cash Flow Statement

ABVC Financials

See ABVC Biopharma Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

ABVC Biopharma Inc Earnings Date

Latest Release

May 18, 2026

EPS / Forecast

-0.06/--

Revenue / Forecast

0.00/--

See Upcoming Earnings >>

Period

FY2025 Earnings

Revenue(YoY)

-100.00%

EPS(YoY)

-0.39

6.36%

Analyst Rating

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

Financial Indicators

EPS

-8.98%-0.06

-929.30%-0.14

-256.38%-0.05

-55.95%-0.13

80.67%-0.06

130.25%0.02

98.16%-0.02

87.83%-0.08

47.21%-0.29

96.09%-0.06

---0.82

---0.68

---0.55

---1.47

---3.71

----

Revenue

--0.00

----

104.47%795.95K

-100.00%0.00

-9.19%1.97K

2350.74%389.28K

1817.53%117.14K

-99.06%1.21K

-99.63%2.17K

-62.42%15.88K

-98.05%6.11K

399.89%128.27K

--588.99K

-57.30%42.27K

895.07%312.86K

-90.25%25.66K

----

-14.33%99.00K

-86.12%31.44K

234.01%263.15K

Net Profit

-85.29%-1.56M

-1653.81%-3.56M

-568.15%-1.25M

-122.88%-2.26M

70.29%-842.08K

159.82%229.30K

94.38%-186.56K

55.26%-1.01M

-55.41%-2.83M

92.12%-383.33K

10.46%-3.32M

-21.76%-2.26M

69.58%-1.82M

---4.86M

-105.09%-3.70M

5.71%-1.86M

-431.27%-6.00M

----

2.14%-1.81M

-6.61%-1.97M

9.54%-1.13M

Net Margin

----

-368.97%-161.76%

----

120.28%6558.65%

99.84%-34.49%

97.64%-894.14%

-16326.56%-242959.92%

-4132.95%-32346.84%

---21204.23%

---37898.59%

---1479.07%

---764.17%

---3101.84%

----

Gross Margin

----

0.08%100.00%

----

101.58%100.00%

215.60%99.92%

109.12%99.84%

45.20%77.01%

-11621.73%-6329.84%

---86.44%

---1094.65%

--53.04%

--54.94%

--94.48%

----

Debt to assets ratio

-59.12%4.50%

-68.92%7.38%

-61.40%4.85%

-43.75%6.93%

-6.58%11.00%

3.51%23.74%

-16.77%12.57%

-72.53%12.33%

-69.22%11.78%

16.04%22.94%

--15.11%

--44.87%

--38.27%

--19.77%

--17.81%

----

Income Statement

Revenue

--0.00

----

104.47%795.95K

-100.00%0.00

-9.19%1.97K

2350.74%389.28K

1817.53%117.14K

-99.06%1.21K

-99.63%2.17K

-62.42%15.88K

-98.05%6.11K

399.89%128.27K

--588.99K

-57.30%42.27K

895.07%312.86K

-90.25%25.66K

----

-14.33%99.00K

-86.12%31.44K

234.01%263.15K

Operating profit

-126.91%-1.57M

-796.24%-2.99M

-2439.30%-1.17M

-134.99%-2.29M

75.58%-693.00K

34.71%-334.16K

102.32%49.95K

55.48%-976.64K

-48.90%-2.84M

83.66%-511.84K

42.01%-2.15M

-7.18%-2.19M

69.35%-1.91M

---3.13M

-88.57%-3.72M

-0.56%-2.05M

-396.41%-6.22M

----

-52.78%-1.97M

-70.48%-2.04M

-6.95%-1.25M

Net Profit

-85.29%-1.56M

-1653.81%-3.56M

-568.15%-1.25M

-122.88%-2.26M

70.29%-842.08K

159.82%229.30K

94.38%-186.56K

55.26%-1.01M

-55.41%-2.83M

92.12%-383.33K

10.46%-3.32M

-21.76%-2.26M

69.58%-1.82M

---4.86M

-105.09%-3.70M

5.71%-1.86M

-431.27%-6.00M

----

2.14%-1.81M

-6.61%-1.97M

9.54%-1.13M

Balance Sheet

Current assets

-55.85%648.85K

14.75%2.50M

89.57%4.07M

26.53%2.77M

-18.11%1.47M

31.58%2.18M

-13.84%2.15M

2.85%2.19M

-48.44%1.79M

-44.54%1.66M

-14.11%2.49M

-78.25%2.13M

-56.43%3.48M

-68.96%2.99M

-59.17%2.90M

169.86%9.79M

53.45%7.99M

55.92%9.63M

503.76%7.11M

126.04%3.63M

----

Total current liabilities

-19.87%5.39M

-6.00%6.16M

3.04%6.51M

-0.25%6.53M

1.46%6.73M

7.47%6.56M

17.76%6.32M

13.44%6.55M

30.71%6.63M

10.07%6.10M

37.72%5.36M

58.34%5.77M

38.52%5.07M

50.14%5.54M

13.24%3.89M

-16.69%3.65M

-21.49%3.66M

-23.78%3.69M

-43.12%3.44M

-42.23%4.38M

----

Total assets

32.65%19.73M

179.34%21.06M

46.42%21.18M

10.98%16.24M

2.87%14.88M

-3.14%7.54M

-12.83%14.46M

57.01%14.63M

34.70%14.46M

-18.74%7.78M

58.31%16.59M

-32.38%9.32M

-11.04%10.73M

-30.07%9.58M

-15.17%10.48M

54.08%13.78M

14.64%12.07M

18.02%13.70M

89.22%12.35M

39.06%8.94M

----

Total liabilities

-0.22%6.90M

13.92%7.76M

3.09%6.68M

-0.79%6.75M

-0.77%6.92M

4.36%6.82M

-13.90%6.48M

-29.75%6.81M

-22.52%6.97M

2.96%6.53M

57.29%7.53M

110.50%9.69M

91.28%9.00M

31.40%6.34M

0.47%4.79M

-45.40%4.60M

-46.51%4.71M

-46.03%4.83M

-38.29%4.77M

7.02%8.43M

----

Total equity

61.24%12.83M

1736.77%13.30M

81.63%14.49M

21.22%9.49M

6.27%7.96M

-42.24%723.96K

-11.94%7.98M

2232.99%7.83M

331.65%7.49M

-61.27%1.25M

59.17%9.06M

-104.00%-367.01K

-76.44%1.73M

-63.52%3.24M

-24.99%5.69M

1679.20%9.18M

325.85%7.36M

233.21%8.87M

736.81%7.59M

135.73%515.99K

----

Cash Flow Statement

Net operating income

-65.65%-894.24K

-187.48%-1.42M

-177.60%-133.26K

11.83%-894.17K

43.52%-539.83K

-14.67%-493.61K

112.64%171.72K

-12.70%-1.01M

36.18%-955.82K

6.64%-430.46K

-164.53%-1.36M

73.76%-899.83K

49.98%-1.50M

77.58%-461.07K

80.86%-513.70K

-137.49%-3.43M

-111.90%-2.99M

6.03%-2.06M

-716.44%-2.68M

-1.97%-1.44M

----

Net investment

--47.12K

--730.35K

---1.27M

---665.78K

--0.00

-100.00%0.00

----

--0.00

285.11%154.17K

95.16%-73.78K

-1900.25%-440.57K

100.00%0.00

-100.26%-83.29K

-344.84%-1.52M

84.27%-22.03K

66.94%-93.22K

-138.83%-41.59K

6.41%-342.40K

-520.49%-140.02K

----

Net financing

-179.81%-342.18K

97.70%1.15M

878.85%1.13M

121.90%1.93M

-53.61%428.76K

1413.38%581.46K

-108.78%-145.39K

2849.68%868.54K

-58.12%924.15K

115.16%38.42K

174.49%1.66M

-100.86%-31.59K

--2.21M

-105.96%-253.50K

-89.63%603.50K

3232.63%3.66M

-100.00%0.00

-38.09%4.25M

1211.17%5.82M

-107.11%-116.96K

----

FAQs

What are the current assets of ABVC Biopharma Inc?



According to ABVC Biopharma Inc's FY2025 earnings report, its current assets were 2.50M, with a year-on-year change of 14.75.

What are the total assets of ABVC Biopharma Inc?



According to ABVC Biopharma Inc's FY2025 earnings report, its total assets of ABVC Biopharma Inc were 21.06M, with a year-on-year change of 179.34.

What are the total liabilities of ABVC Biopharma Inc?



According to ABVC Biopharma Inc's FY2025 earnings report, its total liabilities of ABVC Biopharma Inc were 7.76M, with a year-on-year change of 13.92.

What is the total equity of ABVC Biopharma Inc?



According to ABVC Biopharma Inc's FY2025 earnings report, its total equity of ABVC Biopharma Inc was 13.30M, with a year-on-year change of 1736.77.

What is the net operating income of ABVC Biopharma Inc?



According to ABVC Biopharma Inc's FY2025 earnings report, its net operating income of ABVC Biopharma Inc was -7.15M, with a year-on-year change of -51.98.

What is the net financing of ABVC Biopharma Inc?



According to ABVC Biopharma Inc's FY2025 earnings report, its net financing of ABVC Biopharma Inc was 4.64M, with a year-on-year change of 134.15.

What is the Earnings Per Share (EPS) of ABVC Biopharma Inc?



According to ABVC Biopharma Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.39, with a year-on-year change of 6.36.

What is the net income of ABVC Biopharma Inc?



According to ABVC Biopharma Inc's FY2025 earnings report, its net income was -7.91M, with a year-on-year change of -61.30.

What is the debt-to-asset ratio of ABVC Biopharma Inc?



According to ABVC Biopharma Inc's FY2025 earnings report, its debt-to-asset ratio was 7.38, with a year-on-year change of -68.92.

What is the Return on Equity (ROE) of ABVC Biopharma Inc?



According to ABVC Biopharma Inc's FY2025 earnings report, its Return on Equity (ROE) was -128.20, with a year-on-year change of 63.65.

What is the Return on Assets (ROA) of ABVC Biopharma Inc?



According to ABVC Biopharma Inc's FY2025 earnings report, its Return on Assets (ROA) was -58.58, with a year-on-year change of 14.66.

What is the operating profit of ABVC Biopharma Inc?



According to ABVC Biopharma Inc's FY2025 earnings report, its operating profit was -7.15M, with a year-on-year change of -51.98.